Literature DB >> 7509827

Activated CD4+ T cells induce CD40-dependent proliferation of human B cell precursors.

N Renard1, V Duvert, D Blanchard, J Banchereau, S Saeland.   

Abstract

Anti-CD3-activated human CD4+ T cell clones were found to induce proliferation of CD10+, CD19+, surface(s) Ig- B cell precursors (BCP) isolated from human fetal bone marrow. The great majority of the B lineage cells recovered in cocultures of BCP and activated T cells displayed a BCP phenotype (Ig- or cytoplasmic mu+ and kappa/lambda-), including most of the cycling cells, indicating that the cultures do not favor a transition to mature B cells. Supernatants of activated T cells were ineffective in inducing BCP proliferation, indicating the necessity of close association with stimulator cells. In line with this finding, the CD40 molecule was found to represent an important component of the cocultures, as BCP proliferation was strongly inhibited by soluble anti-CD40 antibody. In addition, CD4+ T cell clones from a hyper-IgM patient expressing a truncated CD40 ligand (CD40-L) failed to induce BCP proliferation. Finally, a combination of cytokines (IL-2, IL-3, IL-7, and IL-10) enhanced the observed T cell-dependent BCP proliferation, but could not substitute for the deficient CD40-L. Taken together, our data demonstrate that CD4+ T cells exert a stimulatory effect on in vitro B human lymphopoiesis via the CD40 pathway. The present results suggest that T cells may play an important role in regulating B cell ontogeny in the bone marrow.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509827

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Establishment of long-term CD154-dependent porcine B-cell cultures.

Authors:  H Takamatsu; J K Andersen; M S Denyer; R M Parkhouse
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

2.  Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice.

Authors:  S Funakoshi; D D Taub; M R Anver; A Raziuddin; O Asai; V Reddy; H Rager; W C Fanslow; D L Longo; W J Murphy
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

3.  Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.

Authors:  Ashwini S Phadnis-Moghe; Robert B Crawford; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2014-12-26       Impact factor: 4.849

4.  CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells.

Authors:  Denise A Kaminski; Byung O Lee; Sheri M Eaton; Laura Haynes; Troy D Randall
Journal:  Immunology       Date:  2008-12-13       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.